Literature DB >> 12414286

In vivo serotonin 5HT(2A) receptor binding and personality traits in healthy subjects: a positron emission tomography study.

F M Moresco1, M Dieci, A Vita, C Messa, C Gobbo, L Galli, G Rizzo, A Panzacchi, L De Peri, G Invernizzi, F Fazio.   

Abstract

Using positron emission tomography (PET) and [(11)C]raclopride, an association between striatal D(2) dopamine receptors and emotional detachment has been recently reported. Several laboratory findings indicate a link between the serotoninergic system and harm avoidance. In this study we investigated, in a group of healthy volunteers, the relationship between the in vivo binding of 3-(2'-[(18)F]fluoroethyl)spiperone ([(18)F]FESP) to cortical 5HT(2) and striatal D(2) receptors and three personality dimensions, i.e., "novelty seeking," "reward dependence," and "harm avoidance." Eleven healthy volunteers were evaluated by means of the Tridimensional personality Questionnaire (C. R., Arch. Gen. Psychiatry 44: 573-588.) and underwent a PET scan with [(18)F]FESP. Harm avoidance showed a significant inverse correlation with [(18)F]FESP binding in the cerebral cortex, particularly in the frontal cortex (R(2) = -0.709, P = 0.0145) and left parietal cortex (R = -0.629, P = 0.038) but not in the basal ganglia (r = -0.176, P = 0.651). Similar results were obtained using SPM at a P threshold of 0.05. No significant correlation was observed with novelty seeking or reward dependence. In the cerebral cortex, high values of [(18)F]FESP binding values are associated with a high tendency to avoid danger, indicating involvement of the serotoninergic system and, in particular, 5HT(2A) receptors, in this trait of personality. The results of this as well as of previous studies on personality dimensions indicate the existence of a relationship between behavioral and neurobiological factors. In addition these results support the concept that the variability of PET data may be explained by neurochemical differences related to the prevalence of specific personality traits.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414286     DOI: 10.1006/nimg.2002.1239

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  24 in total

Review 1.  The development, past achievements, and future directions of brain PET.

Authors:  Terry Jones; Eugenii A Rabiner
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

2.  Molecular imaging of individual behaviour.

Authors:  R M Moresco; F Fazio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-06       Impact factor: 9.236

Review 3.  Current status of functional imaging in eating disorders.

Authors:  Guido K W Frank; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2012-04-25       Impact factor: 4.861

4.  Gender, personality, and serotonin-2A receptor binding in healthy subjects.

Authors:  Paul H Soloff; Julie C Price; Neale Scott Mason; Carl Becker; Carolyn C Meltzer
Journal:  Psychiatry Res       Date:  2010-01-30       Impact factor: 3.222

5.  Personality and the acute subjective effects of d-amphetamine in humans.

Authors:  Matthew G Kirkpatrick; Chris-Ellyn Johanson; Harriet de Wit
Journal:  J Psychopharmacol       Date:  2013-01-23       Impact factor: 4.153

6.  Trait Openness and serotonin 2A receptors in healthy volunteers: A positron emission tomography study.

Authors:  Dea Siggaard Stenbaek; Sara Kristiansen; Daniel Burmester; Martin Korsbak Madsen; Vibe Gedsoe Frokjaer; Gitte Moos Knudsen; Patrick MacDonald Fisher
Journal:  Hum Brain Mapp       Date:  2019-01-11       Impact factor: 5.038

7.  5-HT1A receptor activation is necessary for 5-MeODMT-dependent potentiation of feeding inhibition.

Authors:  Vikas Duvvuri; Victoria B Risbrough; Walter H Kaye; Mark A Geyer
Journal:  Pharmacol Biochem Behav       Date:  2009-05-31       Impact factor: 3.533

Review 8.  Neurobiology of anorexia and bulimia nervosa.

Authors:  Walter Kaye
Journal:  Physiol Behav       Date:  2007-11-29

9.  Altered 5-HT(2A) receptor binding after recovery from bulimia-type anorexia nervosa: relationships to harm avoidance and drive for thinness.

Authors:  Ursula F Bailer; Julie C Price; Carolyn C Meltzer; Chester A Mathis; Guido K Frank; Lisa Weissfeld; Claire W McConaha; Shannan E Henry; Sarah Brooks-Achenbach; Nicole C Barbarich; Walter H Kaye
Journal:  Neuropsychopharmacology       Date:  2004-06       Impact factor: 7.853

10.  Novelty seeking and harm avoidance in Parkinson's disease: effects of asymmetric dopamine deficiency.

Authors:  R Tomer; J Aharon-Peretz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.